UA112552C2 - HETEROCYCLYLAMINS AS PI3K INHIBITORS - Google Patents

HETEROCYCLYLAMINS AS PI3K INHIBITORS

Info

Publication number
UA112552C2
UA112552C2 UAA201403331A UAA201403331A UA112552C2 UA 112552 C2 UA112552 C2 UA 112552C2 UA A201403331 A UAA201403331 A UA A201403331A UA A201403331 A UAA201403331 A UA A201403331A UA 112552 C2 UA112552 C2 UA 112552C2
Authority
UA
Ukraine
Prior art keywords
heterocyclylamins
pi3k inhibitors
pi3k
activity
diseases
Prior art date
Application number
UAA201403331A
Other languages
Ukrainian (uk)
Inventor
Юнь-Лун Лі
Веньцин Яо
Ендрю П. Комбс
Едді В. Юе
Сун Мей
Веньюй Чжу
Джозеф Глєнн
мол. Мадускуі Томас П.
Річард Б. Спаркс
Брент Дауті
Чуньхун Хе
Original Assignee
Інсайт Холдінгс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інсайт Холдінгс Корпорейшн filed Critical Інсайт Холдінгс Корпорейшн
Priority claimed from PCT/US2012/053398 external-priority patent/WO2013033569A1/en
Publication of UA112552C2 publication Critical patent/UA112552C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В цьому винаході представлені похідні гетероцикліламіну Формули І:, Iде змінні є такими, як описано в цьому документі, які модулюють активність фосфоінозитид-3-кіназ (РІ3K) і придатні для лікування захворювань, пов'язаних з активністю РІ3K, включаючи, наприклад, запальні розлади, імунні розлади, рак і інші захворювання.The present invention provides heterocyclylamine derivatives of Formula I :, the following variables are as described herein that modulate the activity of phosphoinositide-3-kinases (PI3K) and are suitable for the treatment of diseases associated with PI3K activity, including, for example, inflammatory disorders, immune disorders, cancer and other diseases.

UAA201403331A 2011-09-02 2012-08-31 HETEROCYCLYLAMINS AS PI3K INHIBITORS UA112552C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161530866P 2011-09-02 2011-09-02
PCT/US2012/053398 WO2013033569A1 (en) 2011-09-02 2012-08-31 Heterocyclylamines as pi3k inhibitors

Publications (1)

Publication Number Publication Date
UA112552C2 true UA112552C2 (en) 2016-09-26

Family

ID=56998328

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201403331A UA112552C2 (en) 2011-09-02 2012-08-31 HETEROCYCLYLAMINS AS PI3K INHIBITORS

Country Status (2)

Country Link
AR (1) AR116429A2 (en)
UA (1) UA112552C2 (en)

Also Published As

Publication number Publication date
AR116429A2 (en) 2021-05-05

Similar Documents

Publication Publication Date Title
PH12019502246A1 (en) Heterocyclylamines as p13k inhibitors
CY1120866T1 (en) DNA-PK INHIBITORS
PH12018502125A1 (en) Bipyrazole derivatives as jak inhibitors
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
EA201270100A1 (en) Pyrimidinones as PI3K inhibitors
EA201490042A1 (en) AZETIDINYL-PHENYL-, PYRIDYL- OR PYRAZYNYLKARBOXAMID DERIVATIVES AS INHIBITORS
MX362550B (en) Heterocyclic inhibitors of glutaminase.
NZ720478A (en) Autotaxin inhibitor compounds
MX2015011273A (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kî´ related disorders.
PH12016501160A1 (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
GEP20166474B (en) Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
MX2016008042A (en) Imidazopyrazinone derivatives.
MX2017003016A (en) Pyridazinone derivatives as phosphoinositide 3-kinases inhibitors.
UA112552C2 (en) HETEROCYCLYLAMINS AS PI3K INHIBITORS
MX369393B (en) Phthalazine derivatives.
EA201991791A3 (en) HETEROCYCLYLAMINES AS PI3K INHIBITORS
EA201270727A1 (en) PURINE CONNECTIONS
UA110978C2 (en) Azetidinylphenyl, pyridyl or pyrazinylcarboxamide derivatives as JAK inhibitors
UA108989C2 (en) Pyrimidinones as p13k inhibitors
TR201901937T4 (en) 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds.